Leadership Group
The CITF Leadership Group includes experts from across Canada in matters related to serologic surveillance, immunology, virology, infectious diseases, public health, and clinical medicine. It also includes ex-officio members representing agencies of the Government of Canada, including the Public Health Agency of Canada (PHAC), the Canadian Institutes of Health Research (CIHR), and the office of the Chief Scientific Advisor to the Prime Minister, as well as representatives of Provincial-Territorial Ministries of Health, and McGill University (host of the Secretariat).
Executive Committee
The Executive Committee is the final funding decision-making body. It comprises the two Co-Chairs, the Executive Director, and six additional rotating members from the Leadership Group. An important condition for membership is that the individual has no intent to hold or seek funds from the CITF, either as a Principal Investigator or a Co-Investigator on a project being funded by the CITF.
Co-Chairs and Executive Director
Executive Committee members
Government of Canada representatives
Leadership Group members
Provincial & Territorial representatives
Indigenous Advisory Circle
The work of the Indigenous Advisory Circle (IAC) has come to a conclusion. The CITF expresses its deepest thanks to all members for their efforts and contributions. As results from CITF-supported studies emerge bearing on Indigenous communities, the CITF will continue to make efforts to engage Indigenous policy, community and scientific leaders in discussion of their implications.
About the CITF Working Parties
Our Working Parties (WP) are comprised of experts in fields relevant to three strategy priorities: Field Studies, Immune Science & Testing and Vaccine Surveillance.
The Working Parties are responsible for monitoring the scientific landscape in their priority area in Canada (and beyond), articulating a strategy and workplan for the Executive Committee (EC) to review and endorse, and for catalyzing the development and implementation of studies. WPs are expected to review, and where appropriate propose to the EC, a re-direction of priorities as knowledge and context change, identifying supplementary studies necessary to strengthen the scientific relevance and rigour of the CITF.
WPs are led by a member(s) of the Leadership Group. WP membership includes members of the Leadership Group, as well as the Secretariat, and experts external to the CITF as needed and appropriate.
The CITF Working Parties
Field Studies
Working Party Leads: Jim Kellner & Gina Ogilvie
Immune Science and Testing
Working Party Leads: Charu Kaushic and Mel Krajden